We're buying the dip in one of our newest stocks

Jim Cramer's Charitable Trust bought 80 additional BNY shares at roughly $153 after the stock fell about 5.5% over two sessions, lifting its portfolio weighting to approximately 1.25% from 0.95%. BNY management reaffirmed 2026 expectations for 10%-11% revenue growth, 6%-7% expense growth and roughly 400bps of positive operating leverage, while reporting that capital-markets volumes strengthened into September. The purchase views the sector-wide selloff triggered by Bank of America's weaker investment-banking and markets outlook, alongside rising yields and oil prices, as a buying opportunity rather than a change in BNY's underlying outlook.

Analysis

BNY should decouple from BAC only if its asset-servicing, clearing and issuer-services fees prove resilient as market activity normalizes; otherwise the shared sensitivity is not investment banking but lower short-term rates and weaker client asset values. Rising long-end yields are mixed: they can support reinvestment income on BNY's balance sheet, but sustained rate volatility can pressure AUM-linked fees and raise operational collateral demands. The near-term selloff is therefore not automatically a clean relative-value opportunity without confirmation that September activity converts into fee revenue.

The key earnings setup over the next 1-3 months is whether management protects the implied revenue-minus-expense spread despite technology, compliance and restructuring costs. A modest revenue miss can be disproportionately damaging because the valuation case depends on incremental-margin delivery rather than a deeply discounted balance sheet. Watch custody/AUC flows, net interest revenue sensitivity, securities-services fee growth and buyback pace; a reduction in the following-year operating-leverage target would likely compress BNY's premium versus State Street (STT).

Contrarian view: consensus may be treating BNY as a defensive fee compounder while underpricing its cyclicality to equity-market levels, transaction volumes and institutional risk appetite. Conversely, BAC's commentary is a poor direct read-through for BNY, creating an opportunity only if BNY demonstrates that market infrastructure volumes offset any advisory/trading slowdown. BCS is an imperfect but useful risk-on comparator: a broad capital-markets contraction would hurt both, whereas a BNY-specific fee resilience signal favors long BNY versus short BCS or BAC.

Key Decisions for Investors

• Initiate a 1-3 month long BNY / short BAC pair only after BNY holds above the post-selloff low and sector-relative performance stabilizes; target 8-12% relative upside if BNY reaffirms revenue and expense trajectory, with a 4-5% relative stop if BNY cuts its operating-leverage outlook.
• Use STT as the cleaner fundamental cross-check: add BNY only if upcoming disclosures show fee/AUC growth at least in line with STT and no deterioration in net interest revenue. If STT materially outperforms on those metrics, prefer STT rather than averaging BNY.
• Avoid outright long exposure ahead of the next earnings release if the 10-year yield continues rising alongside equity-market weakness; that combination undermines AUM-linked fee assumptions. Reassess on evidence of stable client flows and a maintained buyback authorization.
• Set an alert for any downward revision to the following-year revenue-growth or expense-growth framework. That is thesis-falsifying because the expected multiple support rests on sustained positive operating leverage, not merely current-quarter volume commentary.